ApoC-III Proteoforms, Plasma Lipids, and Cardiovascular Risk in MESA.
Shripad SinariRaymond Q MigrinoYueming HuJeremy FurtadoMajken K JensenMatthew J BudoffDobrin NedelkovRobyn L McClellandDean BillheimerPeter ReavenPublished in: Arteriosclerosis, thrombosis, and vascular biology (2023)
Our data indicate differences in clinical and demographic relationships of apoC-III proteoforms, and highlight the importance of apoC-III proteoform composition in predicting future lipid patterns and cardiovascular disease risk.